NKTREUR Nektar Therapeutics

held by 1 manager in Q4 2019

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.21%	3 mo	NEW	$7M	310,579

Search